cGAS deficiency, genetic disruption of IRF3-dependent signaling, or antibody blockade of the type I IFN receptor in mice results in the downregulation of inflammatory cytokines and chemokines, alleviated inflammatory cell infiltration, and improved cardiac function and survival after MI [44]. This evidence concerns the gene CGAS and myocardial infarction.